2025
pubmed
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk.
Agarwal. Arnav A; Padwal. Raj R
Abstract
GIM/FP/GP: [Formula: see text].
Study Information
Provider
pubmed
Year
2025
Date
2025-10-07T00:00:00.000Z
DOI
10.7326/annals-25-03745-jc